1 Hamilton, M. A., "Trimmed Spearman-Karber method for estimating median lethal concentration in toxicity bioassays" 7 : 714-719, 1977
2 Blanch, L. B., "Topological virtual screening : A way to find new anticonvulsant drugs from chemical diversity" 13 : 2749-2754, 2003
3 Okada, R., "The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures" 480 : 383-387, 1989
4 Lo¨scher, W., "The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices" 9 : 1-10, 1991
5 Alam, O., "Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives" 45 : 2467-2472, 2010
6 Karakurt, A., "Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives" 18 : 2902-2911, 2010
7 Krall, R. J., "Synthesis of 8-alkoxy-4, 5-dihydro-[1, 2, 4]triazole[4, 3-a]quinoline-1-ones and evaluation of their anticonvulsant properties" 19 : 409-, 1978
8 Xian-Yu Sun, "Synthesis of 8-Alkoxy-4,5-dihydro-[1,2,4]triazole[4,3-a]quinoline-1-ones and Evaluation of their Anticonvulsant Properties" 대한약학회 29 (29): 1080-1085, 2006
9 Wei, C. X., "Synthesis of 2-substituted-7-heptyloxy-4, 5-dihydro-[1, 2, 4]-triazolo[ 4, 3-a]quinolin-1(2H)-ones with anticonvulsant activity" 340 : 491-495, 2007
10 Cui, X. S., "Synthesis and anticonvulsant evaluation of 3-substituted-4-(4-hexyloxyphenyl)-4H-1, 2, 4-triazoles" 18 : 49-58, 2009
1 Hamilton, M. A., "Trimmed Spearman-Karber method for estimating median lethal concentration in toxicity bioassays" 7 : 714-719, 1977
2 Blanch, L. B., "Topological virtual screening : A way to find new anticonvulsant drugs from chemical diversity" 13 : 2749-2754, 2003
3 Okada, R., "The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures" 480 : 383-387, 1989
4 Lo¨scher, W., "The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices" 9 : 1-10, 1991
5 Alam, O., "Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives" 45 : 2467-2472, 2010
6 Karakurt, A., "Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives" 18 : 2902-2911, 2010
7 Krall, R. J., "Synthesis of 8-alkoxy-4, 5-dihydro-[1, 2, 4]triazole[4, 3-a]quinoline-1-ones and evaluation of their anticonvulsant properties" 19 : 409-, 1978
8 Xian-Yu Sun, "Synthesis of 8-Alkoxy-4,5-dihydro-[1,2,4]triazole[4,3-a]quinoline-1-ones and Evaluation of their Anticonvulsant Properties" 대한약학회 29 (29): 1080-1085, 2006
9 Wei, C. X., "Synthesis of 2-substituted-7-heptyloxy-4, 5-dihydro-[1, 2, 4]-triazolo[ 4, 3-a]quinolin-1(2H)-ones with anticonvulsant activity" 340 : 491-495, 2007
10 Cui, X. S., "Synthesis and anticonvulsant evaluation of 3-substituted-4-(4-hexyloxyphenyl)-4H-1, 2, 4-triazoles" 18 : 49-58, 2009
11 Arnoldi, A., "Synthesis and anticonvulsant and sedative-hypnotic activity of 4-(alkylimino)-2, 3-dihydro-4H-1-ben-zopyrans and-benzothiopyrans" 33 : 2865-2869, 1990
12 Jin, Y. Z., "Synthesis and anticonvulsant activity study of 7-substituted phenoxyl-4, 5-dihydro[1, 2, 4]triazolo[4, 3-a]quinolines and quinoline-1(2H)-ones" 27 : 1567-1572, 2007
13 Zhang, L. Q., "Synthesis and anticonvulsant activity of some 7-alkoxy-2H-1, 4-benzothiazin-3(4H)-ones and 7-alkoxy-4H-[1, 2, 4]triazolo [4, 3-d]benzo[b][1, 4]thiazines" 58 : 326-331, 2010
14 Deng, X. Q., "Synthesis and anticonvulsant activity of 7-phenyl-6, 7-dihydro-[1, 2, 4]triazolo[1, 5-a]pyrimidin-5(4H)-ones and their derivatives" 46 : 2955-2963, 2010
15 Xie, Z. F., "Synthesis and anticonvulsant activity of 7-alkoxyl-4, 5-dihydro-[1, 2, 4]triazolo[4, 3-a] quinolines" 15 : 4803-4805, 2005
16 Deng, X. Q., "Synthesis and anticonvulsant activity of 7-alkoxy-triazolo-[3, 4-b]benzo[d]thiazoles" 6 : 313-320, 2010
17 Zhang, L., "Synthesis and anticonvulsant activity of 6-alkoxy-[1, 2, 4]triazolo[3, 4-a]phthalazines" 73 : 313-319, 2009
18 Song, M. X., "Synthesis and anticonvulsant activity evaluation of 6-phenyl-7H-[1, 2, 4]triazolo[3, 4-b][1, 3, 4]thiadiazines" 8 : 769-775, 2010
19 Macdonald, R. L., "Specific antagonism of GABA-mediated postsynaptic inhibition in cultured mammalian spinal cord neurons : a common mode of convulsant action" 28 : 325-330, 1978
20 Yi, L., "Six-and four-coordinated zinc(II)complexes exhibit strong blue fluorescent properties" 6 : 1209-1212, 2003
21 Brown, T. R., "Primary care : Epilepsy" 344 : 1145-1151, 2001
22 Stefan, H., "Novel anticonvulsant drugs" 113 : 165-183, 2007
23 Donner, E. J., "New generation anticonvulsants for the treatment of epilepsy in children" 3 : 170-180, 2006
24 Yogeeswari, P., "Neuropathic pain : Strategies in drug discovery and treatment" 2 : 169-184, 2007
25 Estrada, E., "In silico studies for the rational discovery of anticonvulsant compounds" 8 : 2755-2770, 2000
26 Prasad, A. N., "Genetic influences on the risk of epilepsy. In Pediatric epilepsy: Diagnosis and therapy, 3rd ed" Demos Publishers 2001
27 Bernasconi, R., "Gamma-vinyl GABA : Comparison of neurochemical and anticonvulsant effects in mice" 72 : 213-233, 1988
28 Olsen, R. W, "GABA-benzodiazepine-barbiturate receptor interactions" 37 : 1-13, 1981
29 Gale, K., "GABA and epilepsy, basic concepts from preclinical research" 33 : 3-12, 1992
30 Shao, N., "Efficient one-pot formation of 4-N-substituted 2, 4-dihydro-3H-1, 2, 4-triazolin-3-ones from primary amines using N0-(ethoxymethylene)hydrazinecarboxylic acid methyl ester" 47 : 6743-6746, 2006
31 Lo¨scher, W., "Effects of the non-NMDA antagonists NBQX and the 2, 3-benzodiazepine GYKI 52466 on different seizure types in mice : Comparison with diazepam and interactions with flumazenil" 2 : 145-181, 1988
32 McNamara, J. O., "Drugs effective in the therapy of the epilepsies. In Goodman and Gilman’s the pharmacological basis of therapeutics" McGraw-Hill 521-547, 2001
33 Perucca, E., "Development of new antiepileptic drugs : Challenges, incentives, and recent advance" 6 : 793-804, 2007
34 Guo, L. J., "Design and synthesis of 5-alkoxy-[1, 2, 4]triazolo[4, 3-a]quinoline derivatives with anticonvulsant activity" 44 : 954-958, 2009
35 Deng, X.Q., "Design and synthesis of 10-alkoxy-5,6-dihydro-triazolo [4,3-d]benzo[f][1,4]oxazepine derivatives with anticonvulsant activity" 45 : 3080-3086, 2010
36 Pollard, J. R., "Antiepileptic drugs in development" 5 : 1064-1067, 2006
37 Poter, R. J., "Antiepileptic drug development program" 51 : 293-, 1984
38 Jin, H. G., "Anticonvulsant and toxicity evaluation of some 7-alkoxy-4, 5-dihydro-[1, 2, 4]triazolo[4, 3-a]quinoline-1(2H)-ones" 14 : 6868-6873, 2006
39 Hester Jr., J.B., "6-Aryl-4H-s-triazolo[4, 3-a][1, 4]benzodiazepines. Influence of 1-substitution on pharmacological activity" 22 : 1390-1398, 1979
40 Lo¨scher, W, "3-Mercaptopropionic acid : convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine" 28 : 1397-1407, 1979
41 Hester Jr., J.B., "2, 4-Dihydro-6-phenyl-(1H)-triazolo [4, 3-a][1, 4]benzodiazepine-1-ones with antianxiety and antidepressant activity" 23 : 402-405, 1980